Arm shares fall 5% after hours despite Q2 beat as outlook only edges past forecasts

A 5% fall on a beat in both earnings and revenue shows how high the bar had been set, with the market treating guidance that only matches consensus as a disappointment. The reaction may weigh on AI-linked chip names in the regular session, where richly valued stocks have little cushion for anything short of a clear upgrade. The AGI CPU order book offers some longer-term support, but near-term trading is likely to be driven by positioning rather than the delivery timeline. A recovery would probably need clearer signs of the new processor’s revenue contribution.---Earlier:Qualcomm beats Q4 forecasts, shares slip 2% as profit guidance comes in light--- Arm beat on every headline number, but an outlook that only matched expectations was not enough for a stock priced for more.Summary:Adjusted EPS of 52 cents beat forecasts of 47 cents; revenue of about $1.44 billion topped estimates near $1.38 billionQ3 revenue guidance of $1.49 billion to $1.59 billion and adjusted EPS of about 56 cents sit marginally above consensusAnnualised contract value of about $1.79 billion was slightly below expectationsAGI CPU purchase orders extend through calendar 2027, with first commercial deliveries on track for the fourth quarterPartners shipped more than 10 billion Arm-based chips in a quarter for the first time; Arm-based PCs are about 20% of global PC shipmentsShares fell about 5% after hours Arm Holdings shares fell about 5% in after-hours trade despite the chip designer beating expectations for its fiscal second quarter, as investors weighed guidance that only marginally topped forecasts and a slight shortfall in a key licensing measure.Adjusted earnings per share came in at 52 cents, ahead of the 47 cents analysts had expected, while revenue of about $1.44 billion topped forecasts of around $1.38 billion, a beat of a little over 4%.Guidance for the fiscal third quarter was close to consensus. Arm expects revenue of $1.49 billion to $1.59 billion, with the $1.54 billion midpoint just above estimates near $1.53 billion, and adjusted EPS of about 56 cents against forecasts of 55 cents. Adjusted operating expenses are expected at around $825 million, broadly in line with expectations.Annualised contract value, a measure of licensing commitments, came in at about $1.79 billion, marginally below the roughly $1.80 billion expected. The miss was small, but for a stock priced for strong growth, an outlook that merely matches estimates can leave little room for disappointment.The commentary was more upbeat. Arm said purchase orders for its AGI CPU, its data centre processor, now extend through calendar 2027, and that first commercial deliveries remain on track for the fourth quarter. The product marks a shift for a company that has historically licensed designs to chipmakers rather than selling chips itself, and the order book offers early evidence that customers are committing to it.Arm also said its partners shipped more than 10 billion Arm-based chips in a single quarter for the first time, and that Arm-based PCs now account for about 20% of global PC shipments, a sign of the architecture extending beyond its smartphone base.The share reaction suggests investors were looking for a bigger step-up in the outlook than Arm delivered. Attention now turns to whether the AGI CPU deliveries land on schedule and how quickly the processor contributes to revenue, which will be central to whether Arm can justify its growth premium into next year.  This article was written by Eamonn Sheridan at investinglive.com.